AS WE EMBARK ON A NEW DECADE, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH (FNIH) IS PROUD TO CONTINUE SUPPORTING THE FIELD OF BIOMEDICAL RESEARCH. PRESENTED HERE ARE A FEW SIGNIFICANT MILESTONES FROM THE PAST DECADE RESULTING IN MEANINGFUL IMPACT IN HEALTH WORLDWIDE.
Created the infrastructure for unparalleled public-private partnerships to accelerate development of new treatments for chronic diseases like Alzheimer’s disease, type 2 diabetes, rheumatoid arthritis, lupus and Parkinson’s disease, by sharing data publicly to advance the science and establish a model for progress.
Qualified the first clinical safety biomarker ever in the history of the U.S. Food and Drug Administration (FDA), leading to improved detection of drug-induced acute kidney injury in clinical trials.
Developed the first-ever evidence-based criteria to diagnose sarcopenia, which will promote the generation of better therapies to treat this condition.
Revealed that exposures to pathogens in children in low-resource settings leads to significant shortfalls in child development — even in the absence of symptoms of any disease — through a paradigm-shifting study.
Pioneered the use of a master protocol for clinical trials in oncology, leading to rapid acceleration of cancer drug testing, extending treatment access to hundreds of cancer patients and paving the way for master protocol use in other disease areas.